SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Aug 22, 2019
Document Date
Aug 22, 2019
Form Description
EFFECT
Filing Group
Other
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.